Faron Pharmaceuticals LTD: Holding(s) in Company

Faron Pharmaceuticals Ltd reported a decrease in major holdings held by Timo Syrjälä and Acme Investments SPF Sarl. As of June 11, 2026, the combined voting rights for these parties fell to 6.46%, down from a previous position of 7.77%, according to a company announcement filed June 17, 2026.

Why did Faron Pharmaceuticals voting rights change?

The shift in voting rights occurred on June 11, 2026, and was officially notified to the issuer on June 16, 2026. According to the company announcement, the change involved the disposal of voting rights.

Faron Pharmaceuticals also updated its method for defining flagging responsibility on the same date. The company now calculates shares that are registered and issued to Faron and still owned by the firm itself, though these shares cannot vote in meetings. This adjustment brings the new total number of registered Faron shares to 227,881,315.

Did You Know? Faron Pharmaceuticals updated its registry to include shares owned by the company itself, resulting in a total of 227,881,315 registered shares.

Who holds the remaining shares?

The current holding of 6.46% represents 14,712,470 voting rights. This total is split between direct and indirect ownership, as detailed in the Faron Pharmaceuticals filing.

Timo Syrjälä, based in Monaco, holds a direct interest of 2.43%. Acme Investments SPF Sarl, registered in Luxembourg, holds an indirect interest of 4.02%.

Expert Insight: Samantha Carter notes that the dip from 7.77% to 6.46% reflects a specific disposal of voting rights combined with a technical change in how the company calculates its share base. This shift in accounting for treasury shares provides a more comprehensive view of registered shares, even if those specific shares lack voting power.

What happens next for these holdings?

Future notifications may be required if Timo Syrjälä or Acme Investments SPF Sarl cross additional regulatory thresholds. The parties could further adjust their positions through additional acquisitions or disposals of voting rights.

Because Faron is a non-UK issuer, it continues to follow the notification standards required for its listing on the HEL and LSE exchanges.

Frequently Asked Questions

What is the current total percentage of voting rights held by Timo Syrjälä and Acme Investments?
They hold a combined 6.46% of voting rights, totaling 14,712,470 voting rights.

When did the threshold for these holdings change?
The threshold was crossed or reached on June 11, 2026.

How many shares are now registered with Faron Pharmaceuticals?
According to the announcement, there are 227,881,315 registered shares.

How do you think changes in major shareholder holdings affect a company’s long-term stability?